🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

642 results for “Pharma Mar S.A.” Clear

  1. Placebo for ACP-204 capsules

    Pharma Mar S.A.

    Lewy Body Dementia Psychosis (LBDP)

    phase 2 small molecule active

    1 trial

  2. Placebo for AG-946 oral tablet., AG-946, AG-946

    Pharma Mar S.A.

    Sickle Cell Disease

    phase 2 small molecule active

    1 trial

  3. Placebo for MRM-3379, MRM-3379, MRM-3379

    Pharma Mar S.A.

    ​​Fragile X Syndrome​

    phase 2 small molecule active

    1 trial

  4. Placebo for TransCon CNP, TransCon CNP 3.9 mg CNP-38/vial, Navepegritide 2.8 mg CNP(89-126), Navepegritide 1.3 mg CNP(89-126)

    Pharma Mar S.A.

    Achondroplasia in Children and Adolescents

    phase 2 small molecule active

    1 trial

  5. Placebo is identical with the test product and just does not contain active substance.

    Pharma Mar S.A.

    Prurigo Nodularis

    phase 2 small molecule active

    1 trial

  6. Placebo matching REGN9933, REGN7508, REGN9933, Placebo matching REGN7508

    Pharma Mar S.A.

    Venous Thromboembolism

    phase 2 small molecule active

    1 trial

  7. Placebo of Dexamfetamine sulfate 20 mg modified-release capsule, Dexamfetamine sulfate 20 mg modified-release capsule, Attentin 5 mg, Tablette, Dexamfetamine sulfate 15 mg modified-release capsule, Dexamfetamine sulfate 10 mg modified-release capsule, Placebo of Attentin 5 mg 10 mg tablets, Placebo of Dexamfetamine sulfate 15 mg modified-release capsule, Attentin 10 mg Tablette, Placebo of Dexamfetamine sulfate 10 mg modified-release capsule

    Pharma Mar S.A.

    Adults with ADHD and moderate to severe depression

    phase 2 small molecule active

    1 trial

  8. Placebo solution for injection matching COR-1167, COR-1167

    Pharma Mar S.A.

    Worsening Heart Failure

    phase 2 small molecule active

    1 trial

  9. Placebo to Basimglurant (Microcrystalline Cellulose Spheres (Vivapur 1000) and hard Gelatin Capsule, Opaque white body/Opaque white cap, Size 1), Basimglurant, Basimglurant

    Pharma Mar S.A.

    Tuberous Sclerosis Complex

    phase 2 small molecule active

    1 trial

  10. Placebo to match ACP-204

    Pharma Mar S.A.

    Alzheimer Disease psychosis

    phase 2 small molecule active

    1 trial

  11. Placebo to match IMP TEV-56286, Emrusolmin

    Pharma Mar S.A.

    Multiple System Atrophy

    phase 2 small molecule active

    1 trial

  12. Placebo to match buloxibutid oral capsules, Buloxibutid

    Pharma Mar S.A.

    idiopathic pulmonary fibrosis

    phase 2 small molecule active

    1 trial

  13. Placebo, EP262, -, EP262

    Pharma Mar S.A.

    Chronic Spontaneous Urticaria

    phase 2 small molecule active

    1 trial

  14. Placebo, Vacuna Phleum pratense 3000 TBU/ml, Vacuna Phleum pratense 1000 TBU/ml, Test de provocación nasal Phleum pratense, Vacuna Phleum pratense 6000 TBU/ml

    Pharma Mar S.A.

    Allergic rhinitis/rhinoconjunctivitis caused by grass polen allergy

    phase 2 small molecule active

    1 trial

  15. PolyCore

    Pharma Mar S.A.

    End-Stage Kidney Disease

    phase 2 small molecule active

    1 trial

  16. Prednisolon 5 mg JENAPHARM, SPI-62_DF2, Capsule, hard for oral use as placebo for prednisolone., Film-coated tablet for oral use as placebo for Clofutriben (SPI-62)., SPI-62_DF1

    Pharma Mar S.A.

    Polymyalgia rheumatica (PMR)

    phase 2 small molecule active

    1 trial

  17. Public title :A Phase 1b/2a trial to evaluate Invobenitug also known as Procizumab (PCZ; AK1967) in critical cardiovascular care.

    Pharma Mar S.A.

    Cardiogenic shock due to Acute Coronary Syndrome, cardiogenic shock of septic origin or cardiogenic shock due to Acute decompensated Heart Failure

    phase 2 other active

    1 trial

  18. QINLOCK 50 mg tablets

    Pharma Mar S.A.

    Advanced gastrointestinal stromal tumor (GIST)

    phase 2 small molecule active

    1 trial

  19. R7999 matching placebo, REGN7999

    Pharma Mar S.A.

    Non-transfusion dependent beta-thalassemia (NTDT), Beta-thalassemia Resultant Iron overload (IOL)

    phase 2 small molecule active

    1 trial

  20. RBD3000 Placebo Injection is a clear, colorless sterile solution for subcutaneous injection, which is formulated by 25 mM phosphate buffer

    Pharma Mar S.A.

    Mixed Dyslipidemia

    phase 2 small molecule active

    1 trial

  21. RBD4059 injection, Trombyl 75 mg tabletter, The corresponding placebo consist of the 25 mM phosphate buffer solution with 2 µg of vitamin b2 added for colouring purposes only

    Pharma Mar S.A.

    Stable Coronary Artery Disease

    phase 2 small molecule active

    1 trial

  22. REGN13335, Placebo to REGN13335, REGN13335

    Pharma Mar S.A.

    Pulmonary Arterial Hypertension (PAH)

    phase 2 small molecule active

    1 trial

  23. REGN5093

    Pharma Mar S.A.

    MET-altered non-small cell lung cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  24. REGN7041

    Pharma Mar S.A.

    Noninfectious Uveitis

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources